Alpha Diagnostics owner indicted for Medicare fraud; Northwestern University team develops depression Dx;

> The owner of Alpha Diagnostics in Maryland has been indicted for allegedly defrauding Medicare and Medicaid of more than $7.5 million. Story

> Australia's Genetic Technologies will restructure so it can focus more on the U.S. molecular diagnostics market and commercializing its lead breast cancer risk test. Item

> Researchers at Northwestern University believe they've developed a blood-based biomarker panel for major depressive disorder that can successfully identify people with depression versus those that don't have the condition. Story (reg. req.)  

> Former Alere ($ALR) executives are trying to assemble a $3.8 billion takeover of the diagnostics company. Story

> Genome Dx Biosciences is promoting the results of two new studies that it said reinforce the utility of its Decipher prostate cancer genomic test. Release

> Hospitals with Stanford and Duke University are working with Apple ($AAPL) to develop ways to collect data from healthcare apps for diabetes diagnostic monitoring and other uses. Story